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Abstract
We have recently developed image processing techniques for measuring the cortical thicknesses of skeletal structures in
vivo, with resolution surpassing that of the underlying computed tomography system. The resulting thickness maps can be
analysed across cohorts by statistical parametric mapping. Applying these methods to the proximal femurs of osteoporotic
women, we discover targeted and apparently synergistic effects of pharmaceutical osteoporosis therapy and habitual
mechanical load in enhancing bone thickness.
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Introduction
The femur, with its complex load bearing properties and
eventual fragility, has been a key anatomical site of study for
biologists, engineers and anthropologists across several centuries
[1,2,3]. Indeed, the seminal concept of ‘functional adaptation’,
whereby deformation is sensed by bone cells and transduced into
biological signals to optimise skeletal architecture, was based on
observations of proximal femoral structure [1,3,4]. This idea has
long been used to inform orthopaedic practice, and it is in this
tradition that we here address an open question in human bone
biology: where, precisely, is bone regenerated in response to
osteoporosis therapy? With annual hip fracture rates predicted to
exceed six million by 2050, and the distribution of cortical bone in
the proximal femur believed to be the key determinant of fracture
resistance [5,6], this question is of scientific, social and economic
importance. The established clinical intervention to stimulate new
bone formation is parathyroid hormone (PTH), administered by
daily subcutaneous injection [7]. Invasive animal studies point to a
synergistic effect of PTH and localised mechanical stress on bone
cells [8], but the more limited experimental techniques applicable
to living human beings have, to date, revealed only gross
differences in response between heavily loaded sites like the femur
and lightly loaded sites like the radius [7].
Further insight has been hampered by the limited resolution of
whole-body computed tomography (CT) systems and the per-
ceived futility of using such systems to pinpoint tiny changes in
cortical bone distribution. Now, however, a new CT image
processing technique [9] allows us to display cortical thickness as a
colour map over the bone surface (Fig. 1a), with several thousand
independent measurements across each proximal femur and
sufficient sensitivity to detect even small changes (,30 microns)
when expressed systematically by a suitably sized cohort. By making
reasonable assumptions, that the actual cortical density does not vary
dramatically for a given subject at a given time, and that the imaging
blur is roughly Gaussian in shape, thickness can be measured to
super-resolution accuracy, except at the femoral head where the
proximity of the acetabulum is problematic. The methodology has
been validated against gold standard thickness measurements
obtained from micro-CT scans of cadaveric femurs [9].
Methods
Here, we use this technique to map the small changes in cortical
bone distribution stimulated by pharmaceutical treatment for
osteoporosis. In one branch of the EUROFORS study [10], 69
women with severe osteoporosis were treated with recombinant
human PTH (hPTH-(1-34)) for 24 months, with quantitative CT
scans at baseline and 24 months. All data from this cohort was
analysed in the present study, with the exception of those femurs
compromised by metalwork and those where one or both of the
CT scans did not extend as far as the lesser trochanter. This
yielded 119 femurs from 65 women (mean age 67.566.8 years).
Participants were from twelve investigative centres in Germany
and Spain [11]. Institutional Review Board approval was obtained
from each of the clinical study sites, and written informed consent
for EUROFORS (ClinicalTrials.gov ID NCT00191425) and the
QCT sub-study were obtained from each participant. The present
analysis was approved by Cambridgeshire 4 research ethics
committee (LREC07/H0305/61).
Analysis of the 238 thickness maps followed established practice
within the neuroimaging community, who have pioneered
techniques for statistical inference from dense, spatially correlated
data. To account for variations in inter-subject morphology, each
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map was spatially realigned with a canonical femur surface using a
B-spline free-form deformation [12] calculated by the iterative
closest point registration algorithm [13]. The spatially normalized
maps were then smoothed with a 10 mm full-width-half-maximum
filter. Thickness changes were summarised for each subject by
subtracting the baseline maps from the 24-month maps and
averaging the left and right responses where both were available.
This resulted in 65 summarised response maps, 54 derived from
averaged left-right data and 11 from single femurs. Formal
inference was accomplished by statistical parametric mapping
[14], as implemented in the SurfStat package [15]. The model
fitted to the summarised data comprised a constant term and a
random-effect term for left-right averaging: this allows for unequal
variances between the averaged and unaveraged data. T-statistics
were calculated to test the significance of the constant term,
corresponding to positive thickness change. Random field theory
then furnished P-values, corrected for multiple comparisons to
control the overall image-wise chance of false positives.
Results and Discussion
Baseline measurements reveal the anatomical distribution of
cortical thickness seen in advanced osteoporosis (Fig. 2a). The
nonuniformly thin cortex is of clinical relevance, since fractures
commonly traverse the neck (Fig. 1c) or split the trochanteric
region during sideways falls (Fig. 1d) [5]. The variation in thickness
partly reflects femoral growth, with thick bone of the inferomedial
aspect preserved into late adulthood by lifelong functional
adaptation to stress, and a thin cortex apparent superiorly. In
other areas, such as the trochanters and their connecting crest,
thin cortices overlie predominantly trabecular bone near bony sites
of muscle and tendon insertion (entheses). Following hPTH-(1-34)
treatment, and in striking contrast to the expected ageing effects
[5], the percentage change map (Fig. 2b) shows marked cortical
thickening. Figure 2c shows corrected P-maps for positive
thickness change, based on the magnitude of peaks (sensitive to
focal effects) and on the extent of connected clusters exceeding an
Figure 1. Visualising the femur in health and trauma. (a) A cortical thickness map of a healthy adult male femur with thick (blue/green) cortex
at sites of high load during walking, (b) cortical and trabecular bone. Typical fractures in the (c) femoral neck and (d) inter-trochanteric regions.
doi:10.1371/journal.pone.0016190.g001
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uncorrected P-value threshold of 0.001 (sensitive to distributed
effects).
New bone is targeted to regions that predictably encounter high
stress during normal locomotion, namely the infero-medial
junction of the cortex with the load-bearing calcar femorale, and
the head-neck junction of the superior cortex. Both these sites are
commonly involved in fracture. No regions of statistically
significant thinning are apparent. Foci of new bone are also
evident at the entheses of powerful locomotion muscles; on the
greater and lesser trochanters at the attachment sites of the gluteus
medius and psoas, and at the inter-trochanteric insertion of the
quadratus femoris.
Parathyroid hormone is an established clinical intervention to
stimulate new bone formation in human osteoporosis. Previous
studies have shown that hPTH-(1-34) treatment in postmenopaus-
al women with osteoporosis increases cortical thickness at various
skeletal sites, but this is the first to demonstrate the precise regional
effects at one of the key sites of fragility fracture, the human hip.
hPTH-(1-34) is also known to increase porosity (at least early in
treatment) and reduce the mineral density, since new bone
stimulated by the drug is relatively under-mineralised compared to
older bone [16]. The cortical thickness measurement is robust to
any consequent changes to the average cortical density, since the
average density value is estimated independently in each data set.
It is equally robust to any regional changes in the quality of the CT
data, since the extent of the imaging blur is estimated at every
measurement location.
Intriguingly, both load and PTH act rapidly on the entombed
’load sensing’ osteocytes to profoundly reduce secretion of a key
molecular inhibitor of bone formation, sclerostin [17]. Released
from inhibition, the osteoblasts (surface targets of sclerostin) can
then secrete new bone matrix. Fig. 2b suggests a possible
synergistic effect of habitual load and PTH in the human proximal
femur, since peak effects are seen at sites that are highly stressed by
Figure 2. Cortical thickness maps showing severe osteoporosis and the increase in thickness following hPTH-(1-34) treatment. (a)
Medial, superior and posterior views of the average pre-treatment cortical thickness map in advanced osteoporosis showing remnants of thicker,
highly loaded bone (blue/green) at A) the inferomedial cortex and B) the calcar femorale regions. Elsewhere there is thin, sub-millimetre cortex (pink/
red) at key fracture sites including C) the subcapital superior neck region. Also labelled are the insertion sites of key muscles of locomotion; D) gluteus
medius, E) psoas major and F) quadratus femoris (on the inter-trochanteric crest). (b) Post-treatment percentage change and (c) statistical significance
maps which together indicate regeneration of bone at A), B), C), D), E) and F).
doi:10.1371/journal.pone.0016190.g002
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walking. In the light of this, we ask whether hPTH-(1-34)
treatment for osteoporosis might be more effective if combined
with enhanced skeletal loading. Cortical thickness mapping is the
ideal tool to answer this and other open questions in bone biology.
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